OECD (2002). OECD Guidelines for the Testing of Chemicals No. 404: Acute Dermal Irritation/Corrosion, 13 pp. Paris, France: Organisation for Economic Cooperation and Development.
2.
BothamP.A., EarlL.K., FentemJ.H., RoguetR., & van de SandtJ.J.M. (1998). Alternative methods for skin irritation testing: the current status. ECVAM Skin Irritation Task Force Report 1. ATLA26, 195–211.
3.
ZuangV., BallsM., BothamP.A., CoquetteA., CorsiniE., CurrenR.D., ElliottG.R., FentemJ.H., HeylingsJ.R., LiebschM., MedinaJ., RoguetR., van de SandtH., WiemannC., & WorthA.P. (2002). Follow-up to the ECVAM Prevalidation Study on In vitro Tests for Acute Skin Irritation. ECVAM Skin Irritation Task Force Report 2. ATLA30, 109–129.
4.
van de SandtJ., RoguetR., CohenC., EsdaileD., PonecM., CorsiniE., BarkerC., FusenigN., LiebschM., BenfordD., de Brugerolle de FraissinetteA., & FortaschM. (1999). The use of keratinocytes and human skin models for predicting skin irritation. ATLA27, 723–743.
5.
FentemJ.H., BriggsD., ChesnéC., ElliottG.R., HarbellJ.W., HeylingsJ.R., PortesP., RoguetR., van de SandtJ.J.M., & BothamP.A. (2001). A prevalidation study on in vitro tests for acute skin irritation: results and evaluation by the Management Team. Toxicology in Vitro15, 57–93.
6.
FentemJ.H., & BothamP.A. (2002). ECVAMs activities in validating alternative tests for skin corrosion and irritation. ATLA30, Suppl. 2, 61–67.
7.
ECD (2001). Harmonised Integrated Classification System for Human Health and Environmental Hazards of Chemical Substances and Mixtures. OECD series on testing and assessment, 249 pp. Paris. France: Organisation for Economic Cooperation and Development.
8.
RobinsonM.K., OsborneR., & PerkinsM.A. (2000). In vitro and human testing strategies for skin irritation. Annals of the New York Academy of Sciences919, 192–04.
9.
BasketterD.A., ChamberlainM., GriffithsH.A., RowsonM., WhittleE., & YorkM. (1997). The classification of skin irritants by human patch test. Food and Chemical Toxicology35, 845–52.
10.
COLIPA (1995). Cosmetic Product Test Guidelines for the Assessment of Human Skin Compatibility, 22 pp. Brussels, Belgium: COLIPA.
11.
COLPIA (1997). Test Guidelines for the Assessment of Human Skin Tolerance of Potentially Irritant Cosmetic Ingredients, 17 pp. Brussels, Belgium: COLIPA.
12.
PortesP., GrandidierM-H., CohenC., & RoguetR. (2002). Refinement of the EPISKIN™ protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study. Toxicology in Vitro16, 765–770.
13.
HeylingsJ.R., DiotS., EsdaileD.J., FasanoW.J., ManningL.A., & OwenH.M. (2003). A prevalidation study on the in vitro skin irritation function test (SIFT) for prediction of acute skin irritation in vivo: results and evaluation of ECVAM Phase III. Toxicology in Vitro17, 123–138.
14.
FallerC., BracherM., DamiN., & RoguetR. (2002). Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics. Toxicology in Vitro16, 557–572.
15.
PonecM., & KempenaarJ. (1995). Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacology8, 49–59.
16.
TinoisE., TillierJ., GaucherandM., DumasH., TardyM., & ThivoletJ. (1991). In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. Experimental Cell Research193, 310–319.
17.
RoguetR., CohenC., DossouK.G., & RougierA. (1994). EPISKIN, a reconstituted epidermis for assessing in vitro the irritancy of topically applied compounds. Toxicology in Vitro8, 49–59.
18.
RoguetR., CohenC., RoblesC., CourtellemontP., TolleM., GuillotJ.P., & DuteilX. (1998). An interlaboratory study of the reproducibility and relevance of EPISKIN™, a reconstructed human epidermis, in the assessment of cosmetics irritancy. Toxicology in Vitro12, 295–304.
19.
CannonC.L., NealP.J., SoutheeJ.A., KubilusJ., & KlausnerM. (1994). New epidermal model for dermal irritancy testing. Toxicology in Vitro8, 889–891.
20.
EarlL.K., Hall-ManningT.J., & HollandG.H. (1999). The determination of acute chemically induced skin irritation using a human skin model. In Alternatives to Animal Testing II. Proceedings of the Second International Scientific Conference Organised by the European Cosmetic Industry (ed. ClarkD.G., LisanskyS.G., & MacmillanR.), 227 pp. Newbury, UK: CPL Press.
21.
RosdyM., & ClaussL.C. (1990). Complete human epidermal cell differentiation in chemical defined medium at the air–liquid interface on inert filter substrates. Journal of Investigative Dermatology95, 409–414.
22.
de Brugerolle de FraissinetteA., PicarlesV., ChiboutS., KoloppM., MedinaJ., BurtinP., EbelinM.E., OsborneS., MayerF.K., SpakeA., RosdyM., De WeverB., EttlinR.A., & CordierA. (1999). Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles. Cell Biology and Toxicology15, 121–135.
23.
RobinsonM.K., CohenC., de Brugerolle de FraissinetteA., PonecM., WhittleE., & FentemJ.H. (2000). Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products. Food and Chemical Toxicology40, 573–592.
24.
BoelsmaE., TanojoH., BoddéH., & PonecM. (1996). Assessment of the potential irritancy of oleic acid on human skin: evaluation in vitro and in vivo.Toxicology in Vitro10, 729–742.
25.
BoelsmaE., GibbsS., FallerC., & PonecM. (2000). Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation. Acta Dermato-Venerologica80, 82–88.
26.
MedinaJ., de Brugerolle de FraissinetteA., ChiboutS.D., KoloppM., KammermannR., BurtinP., EbelinM.E., & CordierA. (2000). Use of human skin equivalent Apligraf for in vitro assessment of cumulative skin irritation potential of topical products. Toxicology and Applied Pharmacology164, 38–45.
27.
HeylingsJ.R., ClowesH.M., & HughesL. (2001). Comparison of tissue sources for the skin integrity function test (SIFT). Toxicology in Vitro13, 597–600.
28.
CroninM.T.D., DeardenJ.C., WalkerJ.D., & WorthA.P. (2003). Quantitative structure-activity relationships for human health effects: commonalities with other endpoints. Environmental and Toxicological Chemistry22, 1829–1843.
29.
HulzebosE.M., MaslankiewiczL., & WalkerJ.D. (2003). Verification of literature-derived SARs for skin irritation and corrosion. QSAR and Combinatorial Science22, 351–363.
30.
PatlewiczG., RodfordR., & WalkerJ.D. (2003). QSARs for predicting skin and eye irritation. Environmental & Toxicological Chemistry22, 1862–1869.
31.
BarrattM.D. (1996). Quantitative structure-activity relationships for skin irritation and corrosivity of neutral and electrophilic organic chemicals. Toxicology in Vitro10, 247–256.
32.
HayashiH., NakamuraY., HigashiK., KatoH., KishidaF., & KanekoH. (1999). A quantitative structure-activity relationship study of the skin irritation potential of phenols. Toxicology in Vitro13, 915–922.
33.
SmithJ.S., MacinaO.T., SussmanN.B., LusterM.I., & KarolM.H. (2000). A robust structure-activity relationship (SAR) model for esters that cause skin irritation in humans. Toxicological Sciences55, 215–222.
34.
CroninM.T.D., JaworskaJ.S., WalkerJ.D., ComberM.H.I., WattsC.D., & WorthA.P. (2003). Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environmental Health Perspectives10, 1391–1402.
35.
GernerI., GraetschelG., KahlJ., & SchledeE. (2000). Development of a decision support system for the introduction of alternative methods into local irritancy/corrositivity testing strategies. Development of a relational database. ATLA28, 11–28.
36.
GernerI., ZinkeS., GraetschelG., & SchledeE. (2000). Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Creation of fundamental rules for a decision support system. ATLA28, 665–698.
37.
ZinkeS., GernerI., & SchledeE. (2000). Local irritation/corrosion testing strategies: development of a decision support system for the introduction of alternative methods. ATLA28, 29–40.
38.
FentemJ.H., ArcherG.E.B., BallsM., BothamP.A., CurrenR.D., EarlL.K., EsdaileD.J., HolzhütterH.G., & LiebschM. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the Management Team. Toxicology in Vitro12, 483–524.
39.
LiebschM., TraueD., BarrabasC., SpielmannH., UphillP., WilkinsS., WiemannC., KaufmannT., RemmeleM., & HolzhütterH.G. (2000). The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing. ATLA28, 371–401.
40.
ECVAM (1998). Statement on the scientific validity of the EPISKIN™ test (an in vitro test for skin corrosivity). ATLA26, 277–280.
41.
ECVAM (1998). Statement on the scientific validity of the rat skin transcutaneous electrical resistance (TER) test (an in vitro test for skin corrosivity). ATLA26, 275–277.
42.
ECVAM (2000). Statement on the application of the Epiderm™ human skin model for skin corrosivity testing. ATLA28, 365–366.
43.
EU (2000). Annex I to Commission Directive 2000/33/EC adapting to technical progress for the 27th time Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European UnionL136, 91–97.
44.
ECVAM (2001). Statement on the application of the CORROSITEX® assay for skin corrosivity testing. ATLA29, 96–97.
45.
NIH (1999). Corrositex®: an in vitro test method for assessing dermal corrosivity potential of chemicals. NIH Publication No. 99-4495, 236 pp. Research Triangle Park, NC, USA: NIEHS.
46.
BarrattM.D. (1996). Quantitative structure-activity relationships (QSARs) for skin corrosivity of organic acids, bases and phenols: principal components and neural network analysis of extended datasets. Toxicology in Vitro10, 85–94.
47.
WhittleE.G., BarrattM.D., CarterJ.A., BasketterD.A., & ChamberlainM. (1996). The skin corrosivity potential of fatty acids: in vitro rat and human skin testing and QSAR studies. Toxicology in Vitro10, 95–100.
48.
BarrattM.D., BrantomP.G., FentemJ.H., GernerI., WalkerA.P., & WorthA.P. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 1. Selection and distribution of the test chemicals. Toxicology in Vitro12, 471–482.
49.
BarrattM.D., DixitM.B., & JonesP.A. (1996). The use of in vitro cytotoxicity measurements in QSAR methods for the prediction of the skin corrosivity potential of acids. Toxicology in Vitro10, 283–290.
50.
WorthA.P. (2000). The Integrated Use of Physico-chemical and In Vitro Data for Predicting Chemical Toxicity. PhD Thesis, 369 pp. Liverpool John Moores University, UK.
51.
WorthA.P., & CroninM.T.D. (2001). The use of bootstrap resampling to assess the uncertainty of Cooper statistics. ATLA29, 447–459.
52.
WorthA.P., FentemJ.H., BallsM., BothamP.A., CurrenR.D., EarlL.K., EsdaileD.J., & LiebschM. (1998). An evaluation of the proposed OECD testing strategy for skin corrosion. ATLA26, 709–720.
53.
WorthA.P., & CroninM.T.D. (2001). The use of pH measurements to predict the potential of chemicals to cause acute dermal and ocular toxicity. Toxicology169, 119–131.
54.
EU (2004). Annex 2D to Commission Directive 2004/73/EC adapting to technical progress for the 29th time Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances.
55.
NIH (2002). ICCVAM evaluation of EPISKIN™, EpiDerm™ (EPI-200), and the rat skin transcutaneous electrical resistance (TER) assay: in vitro test methods for assessing dermal corrosivity potential of chemicals. NIH Publication No. 02-4502, 196 pp. Research Triangle Park, NC, USA: NIEHS.
56.
OECD (2002). OECD Guidelines for the Testing of Chemicals No. 430. In vitro Skin Corrosion: Trans-cutaneous Electrical Resistance Test (TER), 12 pp. Paris, France: Organisation for Economic Cooperation and Development.
57.
OECD (2002). OECD Guidelines for the Testing of Chemicals No. 431. In vitro Skin Corrosion: Human Skin Model Test, 8 pp. Paris, France: Organisation for Economic Cooperation and Development.
58.
ICCVAM (2002). OECD Guidelines for the Testing of Chemicals. Proposal for a new guideline. In vitro membrane barrier test system for skin corrosion, 16 pp. NC, USA: ICCVAM, NIEHS.